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1. Introduction  
Magnetic particles are currently one of the most important materials in the industrial sector, 
where they have been widely used for biotechnological and biomedical applications such as 
carriers for recovery and for detection of DNA, proteins, viruses, and cells (Perez et al., 2002; 
Kramer et al., 2004; Gonzales and Krishnan, 2005). The major advantage of magnetic 
particles is that they can be easily manipulated by magnetic force, which enables rapid and 
easy separation of target molecules bound to the particles from reaction mixtures 
(Mirzabekov et al., 2000; Gu et al., 2003; Kuhara et al., 2004; Xu et al., 2004). Use of magnetic 
particles is beneficial for complete automation of steps, resulting in minimal manual labor 
and providing more precise results (Sawakami-Kobayashi et al., 2003). Biomolecules such as 
DNA, biotin, and antibodies have been assembled onto magnetic particles and used as 
recognition materials for target recovery, separation, or detection. 
The method chosen for biomolecule assembly is determined by the surface properties of the 
magnetic particles. Various methods of assembly onto magnetic particles have been 
reported such as electrostatic assembly (Goldman et al., 2002), covalent cross-linking 
(Grubisha et al., 2003; Gao et al., 2004) avidin-biotin technology (Gref et al., 2003), membrane 
integration (Mirzabekov et al., 2000; Tanaka et al., 2004), and gene fusion techniques 
(Nakamura et al., 1995b; Yoshino et al., 2004; Yoshino and Matsunaga, 2006). The amount 
and stability of assembled biomolecules and the percentage of active biomolecules among 
assembled molecules are dependent on the method used for coupling. However, the 
fabrication techniques have not been standardized. As applications for magnetic particles in 
the biotechnology field increase, magnetic particles with greater functionality and novel 
methods for their production are in demand. 
Magnetotactic bacteria synthesize uniform, nano-sized magnetite (Fe3O4) particles, which 
are referred to as “bacterial magnetic particles” (BacMPs). A thin lipid bilayer membrane 
envelops the individual BacMP, which confers high and even dispersion in aqueous 
solutions as compared to artificial magnetic particles, making them ideal biotechnological 
materials (Matsunaga et al., 2003). To use these particles for biotechnological applications, it 
is important to attach functional molecules such as proteins, antibodies, peptides, or DNA. 
BacMP-specific proteins have been used as anchor proteins, which facilitate efficient 
localization and appropriate orientation of various functional proteins attached to BacMPs. 
We have developed several methods for modification and assembly of these functional 
organic molecules over the surface of BacMPs using chemical and genetic techniques. In this 
chapter, we describe advanced magnetic particles used in biomedical applications and the 
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methods for bioengineering of these particles. Specific focus is given to the creation of 
functional BacMPs by magnetotactic bacteria and their applications. 
2. Production of functional magnetic particles  
Currently, magnetic particles offer vast potential for ushering in new techniques, especially 
in biomedical applications, as they can be easily manipulated by magnetic force. The 
important characteristics of these particles include (1) immobilization of higher numbers of 
probes onto magnetic particles because particle surfaces are wider than those of a flat 
surface, (2) reduction of reaction times because of good dispersion properties that increase 
reaction efficiency, (3) facilitation of the bound/free separation step with a magnet, without 
centrifugation or filtration, and (4) the use of automated robotic systems for all reaction 
steps. These characteristics offer great benefits for biomedical applications such as rapid and 
precise measurements or separations of bio-targets. Here, the methods for production of 
functional magnetic particles are introduced.   
2.1 Commercialized magnetic particles  
Commercialized magnetic particles are usually composed of superparamagnetic iron oxide 
nanoparticles (Fe3O4 or Fe2O3), which exhibit magnetic properties only in the presence of 
external magnetic fields. These particles are embedded in polymers such as polysaccharides, 
polystyrene, silica, or agarose. Micro-sized magnetic particles can be easily removed from 
suspension with magnets and easily suspended into homogeneous mixtures in the absence of 
an external magnetic field (Ugelstad et al., 1988). Furthermore, functional groups or 
biomolecules for the recognition of targets are conjugated to the polymer surfaces of magnetic 
particles (Fig. 1), and targets can be collected, separated, or detected by the magnetic particles.  
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Fig. 1. Use of general magnetic particles 
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Biotin or streptavidin-assembled magnetic particles, on which complementary nucleic acid 
strands are immobilized, are widely used for the recovery or extraction of specific nucleic acids 
and are marketed worldwide. Moreover, magnetic particles can be used as supports for 
separation or detection of proteins or cells. For example, protein A- or protein G-assembled 
magnetic particles are suitable for antibody purification and are more efficient than column-
purification techniques. 
Currently, polymer magnetic particles marketed as Dynabeads® (Invitrogen, co.) are one of the 
most widely used magnetic particles for biotechnology applications (Sawakami-Kobayashi et 
al., 2003; Prasad et al., 2003). These particles are prepared from mono-sized macroporous 
polystyrene particles that are magnetized by an in situ formation of ferromagnetic materials 
inside the pores. Dynabeads® with diameters of 2.8 m or 4.5 m are the most widely used 
magnetic particles by scientists around the world, particularly in the fields of immunology, 
cellular biology, molecular biology, HLA diagnostics, and microbiology. 
Antibody-immobilized magnetic particles have been used preferentially in target-cell 
separation of leukocytes (Stampfli et al., 1994; Schratzberger et al., 1997; Schwalbe et al., 2006; 
Nakamura et al., 2001) for in vitro diagnosis because of the simpler and more rapid 
methodology as compared to cell sorting using a flow cytometer. These commercially 
available magnetic particles are chemically synthesized compounds of micrometer and 
nanometer sizes. Several cell separation systems using nano-sized magnetic particles, such as 
50-nm iron oxide particles with polysaccharide- (Miltenyi Biotech, co.) or dextran- (StemCell 
Technologies Inc.) coated superparamagnetic nanoparticles, are commercially available 
(Miltenyi, 1995; Wright, 1952). Because these particles are superparamagnetic and are 
preferred for high-gradient magnetic separation, specially-designed magnetic columns that 
produce high magnetic field gradients are required for cell separation (Miltenyi, 1995). Nano-
sized magnetic particles are advantageous for assay sensitivity, rapidity, and precision. 
However, it remains difficult to synthesize nano-sized magnetic particles with uniform size 
and shape that adequately disperse in aqueous solutions. Consequently, advanced techniques 
and high costs are required for the production of nano-sized magnetic particles. 
Magnetic particles are widely used not only as carriers for recovery or detections of bio-
molecules, but also used as probes for magnetic detections, or agent for magnetic-field-
induced heating. Especially, magnetic particles that have high saturation magnetization are 
ideal candidates for MRI contrast agents, and various kinds of magnetic particles have been 
developed and used for diagnoses. Recently, Mulder et. al. developed the paramagnetic 
quantum dots (pQDs) coated with paramagnetic and pegylated lipids which had a high 
relaxivity. The high relaxivity makes the pQDs contrast agent an attractive candidate for 
molecular MRI purposes. This nanoparticulate probe makes it detectable by both MRI and 
fluorescence microscopy (Mulder et al., 2006). It was successful that the synthesis of 
quantum dots with a water-soluble and paramagnetic micellular coating were used as a 
molecular imaging probe for both fluorescence microscopy and MRI. The present study uses 
magnetic nanoparticles as bimodal tools and combines magnetically induced cell labelling 
and magnetic heating. The particles are used in hyperthermia agents, where the magnetic 
particles are heated selectively by application of an high frequency magnetic field (Mulder et 
al., 2006). These magnetic heating treatments using superparamagnetic iron oxide 
nanoparticles continue to be an active area of cancer research. The research aimed to assess 
if a selective and higher magnetic nanoparticles accumulation within tumor cells is due to 
magnetic labeling and consequently a larger heating effect occurs after exposure to an 
alternating magnetic field in order to eliminate labeled tumor cells effectively (Kettering et 
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al., 2007). Moreover, in recent years magnetic devised like giant magnetoresistive (GMR) 
sensors have shown a great potential as sensing elements for biomolecule detection (Baselt 
et al., 1998; Edelstein et al., 2000; Schotter et al., 2004). The GMR biochip based on spin valve 
sensor array and magnetic nanoparticle probes was developed for inexpensive, sensitive 
and reliable DNA detection using plasmid-derived samples (Xu et al., 2008). The 
applications of magnetic particles as probes are increasingly advanced in biomolecule 
quantitative analysis. 
2.2 Magnetic particles produced by magnetotactic bacteria 
Magnetotactic bacteria synthesize nano-sized biomagnetites, otherwise known as bacterial 
magnetic particles (BacMPs), that are enveloped individually by a lipid bilayer membrane 
(Blakemore, 1983). BacMPs are ultrafine magnetite crystals (50-100 nm in diameter) with 
uniform morphology produced by Magnetospirillum magneticum AMB-1 (Fig. 2).  
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Fig. 2. Transmission electron microscopic (TEM) image and schematic diagram of 
Magnetospirillum magneticum AMB-1 (A), bacterial magnetic particles (BacMPs, B) and 
schematic diagram of proteins on the BacMPs surface (C). 
The molecular mechanism of BacMP synthesis involves a multiple-step process that includes 
vesicle formation, iron transport, and magnetite crystallization. This mechanism has been 
studied using genomic, proteomic, and bioinformatic approaches  (Matsunaga et al., 2005; 
Nakamura et al., 1995a; Arakaki et al., 2003; Amemiya et al., 2007) , and a comprehensive 
analysis provided a clear view of the elaborate regulation of BacMP synthesis.   
Techniques for the mass cultivation of magnetotactic bacteria have been developed, 
allowing for a steady supply of BacMPs for industrial applications. Based on the molecular 
mechanism of BacMP formation in M. magneticum AMB-1, designed functional 
nanomaterials have also been developed. Through genetic engineering, functional proteins 
such as enzymes, antibodies, and receptors have been displayed on the surface of BacMPs. 
The display of proteins on BacMPs was achieved using a fusion technique involving anchor 
proteins isolated from magnetotactic bacteria (Nakamura et al., 1995b). Figure 3A shows the 
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procedure for producing functional magnetic particles through genetic engineering of these 
bacteria. Several proteins involved in the magnetic biosynthetic mechanism are embedded 
in the BacMP membrane. In M. magneticum AMB-1, MagA (46.8 kDa), Mms16 (16 kDa), and 
Mms13 (13 kDa) proteins have been used as anchor molecules for displaying functional 
proteins (Nakamura et al., 1995b; Yoshino et al., 2004; Matsunaga et al., 2005; Matsunaga et 
al., 1999; Matsunaga et al., 2000).  
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Fig. 3. Preparation of BacMPs displaying functional proteins. 
(A) The functional protein gene is fused to an anchor gene for display of a functional protein 
on BacMPs. A plasmid harboring the fusion gene is introduced into M. Magneticum AMB-1. 
(B) TEMs of BacMPs displaying protein A which were treated with rabbit IgG after addition 
of gold nanoparticle (5 nm)-labeled anti-rabbit IgG antibodies (1) or anti-human IgG 
antibodies (2). 
MagA was one of the first proteins experimentally demonstrated to be localized on the 
surface of BacMPs (Nakamura et al., 1995a; Nakamura et al., 1993). MagA is a 
transmembrane protein identified from a M. magneticum AMB-1 mutant strain generated by 
transposon mutagenesis (Nakamura et al., 1995a). As proof of localization, luciferase (61 
kDa) was fused to the C-terminus of MagA (Nakamura et al., 1995b). This was the first 
report of protein display on BacMPs using gene fusion techniques. However, the efficiency 
and stability of proteins displayed on BacMPs were limited, and only a few molecules were 
displayed on a single BacMP. 
As research in this field progressed, a more effective and stable method for protein display 
was developed. To establish high levels of expressed proteins displayed on BacMPs, strong 
promoters and stable anchor proteins were identified using M. magneticum AMB-1 genome 
and proteome analysis (Yoshino and Matsunaga, 2005).  
An integral BacMP membrane protein, Mms13, was isolated as a stable anchor molecule, 
and its anchoring properties were confirmed by luciferase fusion studies. The C-terminus of 
Mms13 was expressed on the surface of BacMPs, and Mms13 was tightly bound to the 
magnetite directly, permitting stable localization of luciferase on BacMPs. Consequently, the 
luminescence intensity obtained from BacMPs using Mms13 as an anchor molecule was 
more than 1,000-times greater than when MagA was used. Furthermore, the IgG-binding 
domain of protein A was displayed uniformly on BacMPs using Mms13 (Fig. 3B).  
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Strong promoters and stable anchor proteins allowed efficient display of functional proteins 
on BacMPs. However, the display of particular proteins remained a technical challenge due 
to the cytotoxic effects of the proteins when they were overexpressed in bacterial cells. 
Specifically, transmembrane proteins such as G-protein coupled receptors were still difficult 
to express in magnetotactic bacteria. An inducible protein expression system is often used to 
control the expression dose and timing of transmembrane proteins. Recently, we developed 
a tetracycline-inducible protein expression system in M. magneticum AMB-1 to prevent the 
toxic effects of transmembrane protein expression (Yoshino et al., 2010). This system was 
implemented to obtain the expression of tetraspanin CD81, where the truncated form of 
CD81, including the ligand binding site, was successfully expressed on the surface of 
BacMPs using Mms13 as an anchor protein and the tetracycline-inducible protein expression 
system. These results suggest that the inducible expression system will be a useful tool for 
the expression and display of transmembrane and other potentially cytotoxic proteins on the 
membranes of BacMPs. 
Currently, many types of functional proteins can be displayed at high levels on magnetic 
particles due to the modifications described above. Generally, immobilization of proteins 
onto magnetic particles is performed by chemical cross-linking; however, this can hinder the 
activity of some proteins. Because the amine-reactive cross-linker can bind to proteins in a 
random manner, the target proteins may become inactivated. Furthermore, protein 
orientation on the solid phase is difficult to control during chemical conjugation. To 
overcome these difficulties, protein display on magnetic particles produced by 
magnetotactic bacteria through gene fusion is a promising approach, and the techniques 
have expanded the number of applications. 
3. Applications of magnetic particles 
Magnetic iron oxide particles, such as magnetite (Fe3O4) and maghemite (Ǆ-Fe2O3), are 
widely used in medical and diagnostic applications such as magnetic resonance imaging  
(Gleich and Weizenecker, 2005), cell separation (Miltenyi et al., 1990) , drug delivery (Plank 
et al., 2003), and hyperthermia (Pardoe et al., 2003). To use these particles for 
biotechnological applications, the surface modification of the magnetic particle with 
functional molecules such as proteins, peptides, or DNA must be considered. Previously, 
only DNA- or antibody-immobilized magnetic particles were marketed and used in 
biotechnology; it was suggested that the techniques for the immobilization of enzymes or 
receptors were more complicated and time consuming. However, as the methods for 
assembling functional proteins onto magnetic particles have become simpler and more 
efficient, the applications of magnetic particles have expanded. Here, the applications of 
BacMPs displaying functional proteins such as antibody, enzyme, or receptor are described. 
3.1 Applications of antibody-magnetic particles 
Magnetic particles have been widely used as carriers of antibodies for immunoassay, cell 
separation, and tissue typing (Herr et al., 2006; Tiwari et al., 2003; Weissleder et al., 2005). The 
use of magnetic particles is advantageous for full automation, minimizing manual labor and 
providing more precise results (Sawakami-Kobayashi et al., 2003; Tanaka and Matsunaga, 
2000). In particular, immunomagnetic particles have been used preferentially in target cell 
separation from leukocytes (Stampfli et al., 1994; Schratzberger et al., 1997) for in vitro 
diagnosis, as this provides a more rapid and simple methodology compared with cell 
sorting using a flow cytometer.  
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To immobilize antibody, protein A, which is the antibody-binding protein derived from 
Staphylococcus aureus (Deisenhofer, 1981), has been immobilized on magnetic particles using 
the sequence of the Z-domain, a synthetic analogue of the IgG-binding B-domain. 
Staphylococcus protein A consists of a cell wall binding region and five domains, termed C, B, 
A, D, and E, with C next to the cell wall. The molecular interaction of protein A with IgG is 
well understood, and the binding sites on the Fc domain of IgG1, -2, and -4 have been 
characterized. X-ray analysis has revealed that the B-domain of protein A has two contact 
sites that interact with the Fc domain of IgG (Eliasson and Kogelschatz, 1988) . Based on this 
knowledge, a synthetic Z-domain, which consists of 58 amino acids and is capable of 
binding the Fc domain, has been constructed (Lowenadler et al., 1987) . IgG can bind the Z-
domain on magnetic particles with uniform orientation. 
Z-domain was displayed on bacterial magnetic particles using gene fusion techniques and 
was used to detect human insulin from whole blood by sandwich enzyme immunoassays. 
The experimental procedure was fully automated using a pipetting robot bearing a magnet 
(Tanaka and Matsunaga, 2000). 
Antibody-conjugated BacMPs also can be utilized for cell separation. In general, nano-sized 
magnetic particles, rather than micro-sized particles, are preferred for cell separation 
because separated cells with nano-sized magnetic particles on their surfaces can be used in 
subsequent flow cytometric analysis (Graepler et al., 1998). Additionally, micro-sized 
magnetic particles are more likely to have inhibitory effects on cell growth and 
differentiation after magnetic separation. 
Magnetic separation permits target cells to be isolated directly from crude samples such as 
blood, bone marrow, tissue homogenates, or cultivation media. Compared to other more 
conventional methods of cell separation, magnetic separation may be considered a sample 
enrichment step for further chromatographic and electromigratory analysis. To enrich for 
target cells, cell surface antigens, such as cluster of differentiation (CD) antigens, were used 
as markers. CD8, CD14, CD19, CD20, and CD34 positive cells were efficiently enriched from 
peripheral blood (Kuhara et al., 2004; Matsunaga et al., 2006). The separated CD34 positive 
cells retained the capability of forming colonies as hematopoietic stem cells. 
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Fig. 4. Schematic illustration of cell separation procedures. (A) The initial separation of 
peripheral blood mononuclear cells (PBMCs) from whole blood and the subsequent 
magnetic separation of target cells from PBMCs using magnetic particles followed the 
common procedure. (B) Target cells were separated directly from whole blood using 
magnetic particles in the procedure for direct magnetic cell separation. 
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Protein G from Streptococcus sp (Gronenborn et al., 1991) was also displayed on BacMPs, 
resulting in the expansion of IgG-binding diversity. Direct magnetic separation of immune 
cells from whole blood using protein G-BacMPs binding anti-CD monoclonal antibodies 
was demonstrated (Fig. 4). Using this technique, B lymphocytes (CD19+ cells) or T 
lymphocytes (CD3+ cells) were successfully separated at a high purity. 
To increase cell separation efficiency, a novel functional polypeptide, which functions to 
minimize nonspecific adsorption of magnetic particles to cells, was developed for surface 
modification of BacMPs (Takahashi et al., 2010). Previous reports had shown that the 
hydrophilicity or neutral charge of the particle surface was important for the reduction of 
nonspecific interactions between the nanoparticle and the cell surface (Fang et al., 2009; Patil 
et al., 2007). The designed polypeptide was composed of multiple units consisting of four 
asparagines (N) and one serine (S) residue and was referred to as the NS polypeptide. 
Modification of the surface of a magnetic particle with the NS polypeptide resulted in 
reduction of non-specific particle-particle and particle-cell interactions. NS polypeptides on 
magnetic nanoparticle surfaces function as a barrier to block particle aggregation and 
minimize nonspecific adsorption of cells to the nanoparticles; they also add the ability to 
recognize and bind to target cells by working as a linker to display protein G on the 
nanoparticles (Fig. 5). When the NS polypeptide is used in a single fusion protein as a linker 
to display protein G on magnetic particles, the particle acquires the capacity to specifically 
bind target cells and to avoid nonspecific adsorption of non-target cells. CD19+ cells 
represent 4.1% of leukocytes and in peripheral blood were calculated to be less than 0.004% 
of the total cells. Analysis of magnetically separated cells using flow cytometry revealed that 
CD19+ cells were separated directly from peripheral blood with greater than 95% purity 
using protein G-displaying BacMPs bound to anti-CD19 monoclonal antibodies with the NS 
polypeptide. Purities were approximately 82% when the NS polypeptide was not present.  
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Fig. 5. Effect of NS polypeptide on cell separation. 
(A) Schematic diagram of expression vectors for fusion proteins, Mms13-protein G (1), 
Mms13-(N4S)10–protein G (2), and Mms13-(N4S)20-protein G (3). (B) Correlation between the 
display of NS polypeptide on BacMPs and nonspecific binding of BacMPs to the cell surface. 
The number of RAW 264.7 cells separated using BacMPs displaying protein G (○), BacMPs 
displaying (N4S)10-protein G (×), or BacMPs displaying (N4S)20-protein G (△) were counted, 
and the ratio of nonspecifically separated cells was calculated. (C) Direct magnetic separation of 
CD19+ cells from whole blood using BacMPs displaying (N4S)20-proteins bound to PE-labeled 
anti-CD19 mAbs. 
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Display of fusion proteins (protein G and NS polypeptide) on BacMPs significantly 
improved recognition of and binding to target cells, and minimized adsorption of non-target 
cells. These promising results demonstrated that NS polypeptides may be a powerful and 
valuable tool in various cell associated applications. 
3.2 Applications of enzyme-magnetic particles  
Enzymes can catalyze various biochemical reactions with high efficiency and specificity 
and are therefore used in industrial production (Patil et al., 2007). However, the 
production and purification of recombinant enzymes can be quite time and cost 
consuming. If enzymes could be immobilized on magnetic particles, they could be reused 
following magnetic recovery from the reaction mixture. Enzymes and antibodies 
immobilized on BacMPs using bifunctional reagents and glutaraldehyde have been found 
to have higher activities than those immobilized on artificial magnetic particles 
(Matsunaga and Kamiya, 1987). The luciferase gene (luc) was cloned downstream of the 
MagA promoter and the effect of iron on the regulation of MagA expression was 
investigated; transcription of MagA was found to be enhanced by low concentrations of 
iron. As an initial proof-of-concept experiment for the recovery of enzyme-displaying 
BacMPs, luciferase was assembled onto BacMPs (Nakamura et al., 1995b). The genes for 
acetate kinase and liciferase were fused to the N- and C-terminus of the MagA anchor 
protein for simultaneous display of two different enzymes (Matsunaga et al., 2000). 
Acetate kinase catalyzes the phosphorylation of acetate by ATP. Therefore, this reversible 
reaction generates ATP in the presence of ADP and acetyl phosphate. The results 
presented in Fig. 6 are consistent with the hypothesis that ATP is generated in situ by 
acetate kinase present on BacMPs through phosphorylation of ADP to ATP (Fig. 6). Thus, 
protein-BacMPs complexes were constructed by joining the luciferase gene to the N- or 
the C-terminal domains of MagA, and also constructed bifunctional active fusion proteins 
on BacMPs using MagA as an anchor with acetate kinase and luciferase. 
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Fig. 6. Simultaneous display of two different enzymes, acetate kinase (ackA) and luciferase 
(luc), onto BacMPs. (A) Schematic diagram of fusion genes, and (B) luciferase activity on 
BacMPs  
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A highly thermostable enzyme, pyruvate phosphate dikinase (PPDK), which converts 
pyrophosphate PPi to ATP, was also expressed on BacMPs. Pyrosequencing relies on the 
incorporation of nucleotides by DNA polymerase, which results in the release of PPi. The 
ATP produced by PPDK-displaying BacMPs can be used by luciferase in a luminescent 
reaction (Fig. 7). PPDK-displaying BacMPs were employed in a pyrosequencing reaction 
and a target oligonucleotide was successfully sequenced (Yoshino et al., 2009). The PPDK 
enzyme was recyclable in each sequence reaction as it was immobilized onto BacMPs which 
could be manipulated by a magnet. These results illustrate the advantages of using enzyme-
displaying BacMPs as biocatalysts for repeat usage. Nano-sized PPDK-displaying BacMPs 
are useful for the scale-down of pyrosequencing reaction volumes, thus permitting high-
throughput data acquisition. 
 
 
Fig. 7. Schematic diagram of the principle of pyrosequencing using PPDK-BacMPs. PEP: 
phosphoenolpyruvate, PPi: pyrophosphate, Pi: phosphate, PPDK: Pyruvate phosphate 
dikinase. PEP : phosphoenolpyruvate, PPi : pyrophosphate, Pi : phosphate, PPDK : Pyruvate 
phosphate dikinase  
3.3 Applications of receptor-magnetic particles  
Along with immunoassays and cell separations, ligand-binding assays to study receptor 
proteins are highly desired applications for magnetic particles. Receptor proteins play 
critical roles in gene expression, cellular metabolism, signal transduction, and intercellular 
communication. In particular, nuclear receptors and transmembrane receptors can be major 
pharmacological targets. These types of receptors have been assembled onto BacMPs.  
The estrogen receptor is a nuclear receptor serving as a ligand-inducible transcriptional 
regulator. In recent decades, it has been suggested that natural and synthetic compounds 
can act as steroid hormones and adversely affect humans and wildlife through interactions 
with the endocrine system. These compounds have been broadly referred to as 
environmental endocrine disrupting chemicals (EDCs). Several chemicals, such as plastic 
softeners (bisphenol A) or detergents (4-nonylphenol), were originally considered harmless, 
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but now are suspected of having estrogenic effects. It is probable that many unidentified 
chemical compounds are potential EDCs.  
To evaluate and detect these chemical compounds, estrogen receptor ligand-binding domain 
(ERLBD) was displayed on BacMPs (Yoshino et al., 2005). ERLBD-BacMP complexes can be 
used for assays based on the competitive binding of alkaline phosphatase conjugated 17ǃ-
estradiol (ALP-E2) as a tracer. The dissociation constant of the receptor was 2.3 nM. 
Inhibition curves were evaluated by the decrease in luminescence intensity resulting from 
the enzymatic reaction of alkaline phosphatase. The overall simplicity of this receptor 
binding assay resulted in a method that could be easily adapted to a high-throughput 
format.  
Subsequent-generation evaluation systems for EDCs can distinguish between agonists and 
antagonists (Yoshino et al., 2008). In one system, ERLBD-displaying BacMPs and green 
fluorescent protein (GFP)-fused coactivator proteins were used in combination, and ERLBD-
displaying BacMPs were incubated with ligands and GFP-coactivators. Binding of the 
agonist to ERLBD induced a conformational change of ERLBD and promoted binding of the 
GFP-coactivator to an ERLBD dimer on the BacMP. Binding of the antagonist to ERLBD 
prevented the GFP-coactivator from binding to the ERLBD-BacMPs. Ligand-dependent 
recruitment assays of GFP-labeled coactivators to ERLBD-BacMPs were performed by 
measuring the fluorescence intensity (Fig. 8A). This method was used to evaluate 17-
estradiol (E2) and estriol (E3) as full agonists, octylphenol (OP) as a partial agonist, and ICI 
182,780 (ICI) as an antagonist (Fig. 8B). The full agonists showed dose-dependent increases 
in fluorescence. Octylphenol had lower fluorescence intensity than E2, and ICI 182,780 did 
not produce fluorescence. The method developed in this study can be used to evaluate the 
estrogenic potential of chemicals by discriminating whether a chemical is an ER full agonist, 
a partial agonist, or an antagonist. This novel method has important potential for screening 
for new EDC candidates and their effects in the environment.  
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Fig. 8. Schematic diagram of the GFP-coactivator recruitment assay (A) and the assay results 
(B). Estrogen receptor ligand binding domain (ERLBD)-BacMPs were incubated with ligand 
and GFP-coactivator. Binding of agonist to ERLBD induced conformation change of ERLBD 
and promoted binding of GFP-coactivator to ERLBD dimmer on BacMPs. Binding of 
antagonist to ERLBD prevented GFP-coactivator binding to ERLBD-BacMPs. 
E2:17ǃEstradiol, E3:Estriol, OP:Octylphenol, ICI:ICI 182780  
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G protein-coupled receptors (GPCRs) play a central role in a wide range of biological 
processes and are prime targets for drug discovery. GPCRs have large hydrophobic 
domains, and therefore, purification of GPCRs from cells is frequently time-consuming and 
typically results in loss of the native conformation. The D1 dopamine receptor, which is a 
GPCR, was successfully assembled into the lipid membrane of BacMPs (Yoshino et al., 2004). 
D1 dopamine receptor-displaying BacMPs were simply extracted by magnetic separation 
from ruptured AMB-1 transformants. This system conveniently retains the native 
conformation of GPCRs without the need for detergent solubilization, purification, and 
reconstitution after cell disruption.  
Additionally, display of the tetraspanin CD81 was demonstrated using the inducible 
expression system (Yoshino et al., 2010) described above. CD81 is utilized when hepatitis C 
virus (HCV) infects hepatocytes and B lymphocytes. Therefore an inhibitor of the human 
CD81-HCV E2 interaction could possibly prevent HCV infection (Pileri et al., 1998). This 
interaction was the motivation behind efforts to produce CD81-displaying BacMPs. 
Consequently, the interaction between BacMPs displaying truncated CD81 and the HCV E2 
envelope were detected, suggesting that CD81-displaying BacMPs could be effectively 
applied to identify inhibitors of the CD81-E2 interaction.  
Transmembrane receptors constitute the most prominent family of validated 
pharmacological targets in biomedicine. Receptor-displaying BacMPs were readily extracted 
from ruptured AMB-1 transformants by magnetic separation, and after several washings 
were ready for analysis. Moreover, BacMPs are well-suited for use in a fully automated 
ligand-screening system that employs magnetic separation. This type of system facilitates 
rapid buffer exchange and stringent washing, and reduces nonspecific binding. 
4. Automated systems  
The suitability of magnetic particles for use in fully-automated systems is an important 
advantage in solid phases of bioassays. Automated robots bearing magnets permit rapid 
and precise handling of magnetic particles leading to high-throughput analysis. Different 
types of fully-automated systems have been developed to handle the magnetic particles and 
to apply them to nucleotide extraction, gene analysis, and immunoassays. 
Figures 9-11 show the layout of an automated workstation with which magnetic particles 
are collected at the bottom of microtiter plates (Maruyama et al., 2004; Tanaka et al., 2003). 
For fluid handling, the processor is equipped with an automated pipetter (1) that moves in 
the vertical and horizontal directions. The platform contains a disposable tip rack station (2), 
a reagent station (3) that serves as reservoirs for wash buffers, and a reaction station (4) for a 
96-well microtiter plate, where a magnetic field can be applied using a neodymium iron 
boron sintered (Nd-Fe-B) magnet on its underside. One pole of the Nd-Fe-B magnet applies 
a magnetic field to one well (Matsunaga, 2003). Eight poles of the Nd-Fe-B magnet are 
aligned on iron rods, and 12 rods are set on the back side of the microtiter plate to apply 
magnetic fields to the 96 wells. The magnetic field can be switched on (magnetic flux 
density: 318 mT) and off (magnetic flux density: <10 mT) by rotating the rods 180°. The 
reaction station is combined with a heat block with a range of 4–99°C and is configured to 
perform the hybridization step. Heating and magnetic separation can be performed 
simultaneously in one well. This precise thermal control unit is suitable for DNA handling 
and has been used for DNA extraction, SNP detection in the genes for aldehyde 
dehydrogenase 2 (ALDH2) (Maruyama et al., 2004) and transforming growth factor (TGF) 
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(Yoshino et al., 2010), detection of epidermal growth factor receptor (EGFR) mutations in 
non-small cell lung cancer (NSCLC), and determination of microsatellite repeats in the 
human thyroid peroxidase (TPOX) gene (Nakagawa et al., 2007). 
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Fig. 9. Automated magnetic separation system, and magnetic separation is achieved in the 
bottom of microtiter plates. 
Figure 10 shows the layout of an automated workstation with which magnetic particles can 
be separated on the inner surface of pipette tips. The automated system consists of an 
automated eight-way pipette bearing a retractable magnet mounted close to the pipette tips 
(1) a tip rack, (2) a reaction station for a 96-well microtiter plate, and (3) a luminescence 
detection unit. One rack can hold 8 × 3 tips for reactions. For automated magnetic 
separation, the suspension of magnetic particles is aspirated and dispersed using an 
automated pipette bearing a magnet. The automated pipette can move horizontally, and 
magnetic particles collected on the inner surface of pipette tips can be resuspended in the 
subsequent wells by the pipetting action (Matsunaga et al., 2007). As an advantage, this 
system can eliminate the carry-over of reaction mixtures to the following reaction steps. Due 
to precise liquid handling, this workstation is mainly used for highly-sensitive 
immunoassays, though its throughput capacity is less than the above system. Using this 
workstation, a fully-automated immunoassay was developed to detect EDCs (Matsunaga et 
al., 2003; Yoshino et al., 2008), human insulin (Tanaka and Matsunaga, 2000), and a prostate 
cancer marker (prostate specific antigen). 
 
(1) (2) (3)
 
Fig. 10. Automated magnetic separation system, and magnetic separation is achieved on the 
inner surface of pipette tips. 
Figure 11 shows the layout of an automated workstation with which magnetic particles can 
be collected onto a magnetic rod (Ota et al., 2006). This workstation is equipped with eight 
automated pestle units and a spectrophotometer that is interfaced with a photosensor 
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amplifier. The magnetic rod that moves in both vertical and horizontal directions is 
composed of a neodymium–iron–boron (Nd–Fe–B) magnet pole and a covering sheath. 
DNA concentrations and purities are measured in the cuvette using an absorbance 
spectrometer that is integrated with the workstation. Light traverses the solution in the 
cuvette from bottom to top. When magnetic particles are collected from the reaction 
mixture, the core magnetic pole is sheathed, and then magnetic particles are suspended in 
the following step by stirring of the sheath without the core rod. The sheath is used as a 
pestle to gently mix the suspension of magnetic particles and solid samples. Using this 
system, DNA was directly extracted from dried maize powder using aminosilane-modified 
BacMPs. Furthermore, the quantitative detection of genetically-modified maize genes was 
examined by real-time PCR. This system offers rapid assay completion with high DNA 
yields and qualities comparable to those of conventional detergent-based methods. 
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Fig. 11. Automated magnetic separation system, and magnetic separation is achieved onto a 
magnetic rod. 
5. Conclusion 
Magnetic particles have been utilized as biomolecule carriers since the 1970s when applied 
research examined bioreactors using enzyme-immobilized magnetic particles. Since then, 
various types of synthetic and bioengineered magnetic particles have been produced, 
modified, and enhanced. These magnetic particles have been widely used in place of 
centrifugation, filter, and chromatography separations, and applied to purifications of 
biological matter including target cells, proteins, and nucleic acids. More recent advances in 
the bioengineering of magnetic particles produced by magnetotactic bacteria have resulted 
in powerful tools for medical applications as well as basic research. This review focused on 
the applications of BacMPs for recovery or detections of bio-molecule. BacMPs are also 
available for other applications such as MRI contrast agents, and carriers for drug delivery 
systems, and so on. High potential magnetic particles will be developed combining with 
genetic engineering, and especially it is quite easy to control the kinds and numbers of 
proteins-displayed on BacMPs. Furthermore, it is possible to display artificially designed 
proteins or polypeptides onto BacMPs by the same methods. These approaches provide a 
new innovation in material science. Elucidation of the mechanism of magnetic particle 
formation in M. magneticum AMB-1 has provided a roadmap for designing novel 
biomaterials useful in multidisciplinary fields. 
www.intechopen.com
 
The Potential of Genetically Engineered Magnetic Particles in Biomedical Applications 
 
405 
6. References 
Amemiya, Y., Arakaki, A., Staniland, S. S., Tanaka, T. & Matsunaga, T. (2007). Controlled 
formation of magnetite crystal by partial oxidation of ferrous hydroxide in the 
presence of recombinant magnetotactic bacterial protein Mms6. Biomaterials 28: 
5381-5389. 
Arakaki, A., Webb, J. & Matsunaga, T. (2003). A novel protein tightly bound to bacterial 
magnetic particles in Magnetospirillum magneticum strain AMB-1. Journal of 
Biological Chemistry 278(10): 8745-8750. 
Baselt, D. R., Lee, G. U., Natesan, M., Metzger, S. W., Sheehan, P. E. & Colton, R. J. (1998). 
A biosensor based on magnetoresistance technology. Biosensors & Bioelectronics 
13(7-8): 731-739. 
Blakemore, R. (1983). Magnetic bacteria and products derived therefrom. US4385119. 
Deisenhofer, J. (1981). Crystallographic refinement and atomic models of a human Fc 
fragment and its complex with fragment B of protein A from Staphylococcus 
aureus at 2.9- and 2.8-.ANG. resolution. Biochemistry 20(9): 2361-2370. 
Edelstein, R. L., Tamanaha, C. R., Sheehan, P. E., Miller, M. M., Baselt, D. R., Whitman, L. 
J. & Colton, R. J. (2000). The BARC biosensor applied to the detection of 
biological warfare agents. Biosensors & Bioelectronics 14(10-11): 805-813. 
Eliasson, B. & Kogelschatz, U. (1988). UV excimer radiation from dielectric-barrier 
discharges. Applied Physics B-Photophysics and Laser Chemistry 46(4): 299-303. 
Fang, Y. L., Jayaram, H., Shane, T., Kolmakova-Partensky, L., Wu, F., Williams, C., Xiong, 
Y. & Miller, C. (2009). Structure of a prokaryotic virtual proton pump at 3.2 
angstrom resolution. Nature 460(7258): 1040-1043. 
Gao, X. H., Cui, Y. Y., Levenson, R. M., Chung, L. W. K. & Nie, S. M. (2004). In vivo cancer 
targeting and imaging with semiconductor quantum dots. Nature Biotechnology 
22(8): 969-976. 
Gleich, B. & Weizenecker, R. (2005). Tomographic imaging using the nonlinear response 
of magnetic particles. Nature 435(7046): 1214-1217. 
Goldman, E. R., Anderson, G. P., Tran, P. T., Mattoussi, H., Charles, P. T. & Mauro, J. M. 
(2002). Conjugation of luminescent quantum dots with antibodies using an 
engineered adaptor protein to provide new reagents for fluoroimmunoassays. 
Analytical Chemistry 74(4): 841-847. 
Gonzales, M. & Krishnan, K. M. (2005). Synthesis of magnetoliposomes with 
monodisperse iron oxide nanocrystal cores for hyperthermia. Journal of Magnetism 
and Magnetic Materials 293(1): 265-270. 
Graepler, F., Lauer, U. & Gregor, M. (1998). Magnetic cell sorting for parietal cell 
purification using a new monoclonal antibody without influence on cell function. 
Journal of Biochemical and Biophysical Methods 36(2-3): 143-155. 
Gref, R., Couvreur, P., Barratt, G. & Mysiakine, E. (2003). Surface-engineered 
nanoparticles for multiple ligand coupling. Biomaterials 24(24): 4529-4537. 
Gronenborn, A. M., Filpula, D. R., Essig, N. Z., Achari, A., Whitlow, M., Wingfield, P. T. & 
Clore, G. M. (1991). A novel, highly stable fold of the immunoglobulin binding 
domain of streptococcal protein G. Science 253(5020): 657-661. 
www.intechopen.com
 
Biomedical Engineering – From Theory to Applications 
 
406 
Grubisha, D. S., Lipert, R. J., Park, H. Y., Driskell, J. & Porter, M. D. (2003). Femtomolar 
detection of prostate-specific antigen: An immunoassay based on surface-
enhanced Raman scattering and immunogold labels. Analytical Chemistry 75(21): 
5936-5943. 
Gu, H. W., Ho, P. L., Tsang, K. W. T., Wang, L. & Xu, B. (2003). Using biofunctional 
magnetic nanoparticles to capture vancomycin-resistant enterococci and other 
gram-positive bacteria at ultralow concentration. Journal of the American Chemical 
Society 125(51): 15702-15703. 
Herr, J. K., Smith, J. E., Medley, C. D., Shangguan, D. & Tan, W. (2006). Aptamer-
conjugated nanoparticles for selective collection and detection of cancer cells. 
Analytical Chemistry 78(9): 2918-2924. 
Kettering, M., Winter, J., Zeisberger, M., Bremer-Streck, S., Oehring, H., Bergemann, C., 
Alexiou, C., Hergt, R., Halbhuber, K. J., Kaiser, W. A. & Hilger, I. (2007). 
Magnetic nanoparticles as bimodal tools in magnetically induced labelling and 
magnetic heating of tumour cells: an in vitro study. Nanotechnology 18(17). 
Kramer, R. M., Li, C., Carter, D. C., Stone, M. O. & Naik, R. R. (2004). Engineered protein 
cages for nanomaterial synthesis. Journal of the American Chemical Society 126(41): 
13282-13286. 
Kuhara, M., Takeyama, H., Tanaka, T. & Matsunaga, T. (2004). Magnetic cell separation 
using antibody binding with protein a expressed on bacterial magnetic particles. 
Analytical Chemistry 76(21): 6207-6213. 
Lowenadler, B., Jansson, B., Paleus, S., Holmgren, E., Nilsson, B., Moks, T., Palm, G., 
Josephson, S., Philipson, L. & Uhlen, M. (1987). A gene fusion system for 
generating antibodies against short peptides. Gene 58(1): 87-97. 
Maruyama, K., Takeyama, H., Nemoto, E., Tanaka, T., Yoda, K. & Matsunaga, T. (2004). 
Single nucleotide polymorphism detection in aldehyde dehydrogenase 2 
(ALDH2) gene using bacterial magnetic particles based on dissociation curve 
analysis. Biotechnology and Bioengineering 87(6): 687-694. 
Matsunaga, T. & Kamiya, S. (1987). Use of magnetic particles isolated from magnetotactic 
bacteria for enzyme immobilization. Applied Microbiology and Biotechnology 26(4): 
328-332. 
Matsunaga, T., Maeda, Y., Yoshino, T., Takeyama, H., Takahashi, M., Ginya, H., Aasahina, 
J. & Tajima, H. (2007). Fully automated immunoassay for detection of prostate-
specific antigen using nano-magnetic beads and micro-poly styrene bead 
composites, 'Beads on Beads'. Analytica Chimica Acta 597(2): 331-339. 
Matsunaga, T., Okamura, Y., Fukuda, Y., Wahyudi, A. T., Murase, Y. & Takeyama, H. 
(2005). Complete genome sequence of the facultative anaerobic magnetotactic 
bacterium Magnetospirillum sp strain AMB-1. DNA Research 12(3): 157-166. 
Matsunaga, T., Sato, R., Kamiya, S., Tanaka, T. & Takeyama, H. (1999). 
Chemiluminescence enzyme immunoassay using ProteinA-bacterial magnetite 
complex. Journal of Magnetism and Magnetic Materials 194(1-3): 126-131. 
Matsunaga, T., Takahashi, M., Yoshino, T., Kuhara, M. & Takeyama, H. (2006). Magnetic 
separation of CD14(+) cells using antibody binding with protein A expressed on 
www.intechopen.com
 
The Potential of Genetically Engineered Magnetic Particles in Biomedical Applications 
 
407 
bacterial magnetic particles for generating dendritic cells. Biochemical and 
Biophysical Research Communications 350(4): 1019-1025. 
Matsunaga, T., Togo, H., Kikuchi, T. & Tanaka, T. (2000). Production of luciferase-
magnetic particle complex by recombinant Magnetospirillum sp AMB-1. 
Biotechnology and Bioengineering 70(6): 704-709. 
Matsunaga, T., Ueki, F., Obata, K., Tajima, H., Tanaka, T., Takeyama, H., Goda, Y. & 
Fujimoto, S. (2003). Fully automated immunoassay system of endocrine 
disrupting chemicals using monoclonal antibodies chemically conjugated to 
bacterial magnetic particles. Analytica Chimica Acta 475(1-2): 75-83. 
Matsunaga, T., Yoda, K., Udagawa, Y., Nemoto, E. & Maruyama, K. (2003). Hybridization 
apparatus and method for detecting nucleic acid in sample using the same. 
US20030059823. 
Miltenyi, S. (1995). Methods and materials for improved high gradient magnetic 
separation of biological materials. US5411863. 
Miltenyi, S., Muller, W., Weichel, W. & Radbruch, A. (1990). High gradient magnetic cell 
separation with MACS. Cytometry 11(2): 231-238. 
Mirzabekov, T., Kontos, H., Farzan, M., Marasco, W. & Sodroski, J. (2000). Paramagnetic 
proteoliposomes containing a pure, native, and oriented seven-transmembrane 
segment protein, CCR5. Nature Biotechnology 18(6): 649-654. 
Mulder, W. J. M., Koole, R., Brandwijk, R. J., Storm, G., Chin, P. T. K., Strijkers, G. J., 
Donega, C. D., Nicolay, K. & Griffioen, A. W. (2006). Quantum dots with a 
paramagnetic coating as a bimodal molecular imaging probe. Nano Letters 6(1): 1-
6. 
Nakagawa, T., Maruyama, K., Takeyama, H. & Matsunaga, T. (2007). Determination of 
microsatellite repeats in the human thyroid peroxidase (TPOX) gene using an 
automated gene analysis system with nanoscale engineered biomagnetite. 
Biosensors & Bioelectronics 22(9-10): 2276-2281. 
Nakamura, C., Burgess, J. G., Sode, K. & Matsunaga, T. (1995a). An iron-regulated gene, 
magA, encoding an iron transport protein of Magnetospirillum sp. strain AMB-1. 
Journal of Biological Chemistry 270(47): 28392-28396. 
Nakamura, C., Kikuchi, T., Burgess, J. G. & Matsunaga, T. (1995b). Iron-regulated 
expression and membrane localization of the magA protein in Magnetospirillum 
sp. strain AMB-1. Journal of Biochemistry 118(1): 23-27. 
Nakamura, C., Sakaguchi, T., Kudo, S., Burgess, J. G., Sode, J. & Matsunaga, T. (1993). 
Characterization of iron uptake in the magnetic bacterium Aquaspirillum sp. 
AMB-1. Applied Biochemistry and Biotechnology 37(39/40): 169-176. 
Nakamura, M., Decker, K., Chosy, J., Comella, K., Melnik, K., Moore, L., Lasky, L. C., 
Zborowski, M. & Chalmers, J. J. (2001). Separation of a breast cancer cell line from 
human blood using a quadrupole magnetic flow sorter. Biotechnology Progress 
17(6): 1145-1155. 
Ota, H., Lim, T. K., Tanaka, T., Yoshino, T., Harada, M. & Matsunaga, T. (2006). 
Automated DNA extraction from genetically modified maize using aminosilane-
modified bacterial magnetic particles. Journal of Biotechnology 125(3): 361-368. 
www.intechopen.com
 
Biomedical Engineering – From Theory to Applications 
 
408 
Pardoe, H., Clark, P. R., St Pierre, T. G., Moroz, P. & Jones, S. K. (2003). A magnetic 
resonance imaging based method for measurement of tissue iron concentration in 
liver arterially embolized with ferrimagnetic particles designed for magnetic 
hyperthermia treatment of tumors. Magnetic Resonance Imaging 21(5): 483-488. 
Patil, S., Sandberg, A., Heckert, E., Self, W. & Seal, S. (2007). Protein adsorption and 
cellular uptake of cerium oxide nanoparticles as a function of zeta potential. 
Biomaterials 28: 4600-4607. 
Perez, J. M., Josephson, L., O'Loughlin, T., Hogemann, D. & Weissleder, R. (2002). 
Magnetic relaxation switches capable of sensing molecular interactions. Nature 
Biotechnology 20(8): 816-820. 
Pileri, P., Uematsu, Y., Campagnoli, S., Galli, G., Falugi, F., Petracca, R., Weiner, A. J., 
Houghton, M., Rosa, D., Grandi, G. & Abrignani, S. (1998). Binding of hepatitis C 
virus to CD81. Science 282(5390): 938-941. 
Plank, C., Schillinger, U., Scherer, F., Bergemann, C., Remy, J. S., Krotz, F., Anton, M., 
Lausier, J. & Rosenecker, J. (2003). The magnetofection method: Using magnetic 
force to enhance gene delivery. Biological Chemistry 384(5): 737-747. 
Prasad, B. L. V., Stoeva, S. I., Sorensen, C. M., Zaikovski, V. & Klabunde, K. J. (2003). Gold 
nanoparticles as catalysts for polymerization of alkylsilanes to siloxane 
nanowires, filaments, and tubes. Journal of the American Chemical Society 125(35): 
10488-10489. 
Sawakami-Kobayashi, K., Segawa, O., Obata, K., Hornes, E., Yohda, M., Tajima, H. & 
Machida, M. (2003). Multipurpose robot for automated cycle sequencing. 
Biotechniques 34(3): 634-637. 
Schotter, J., Kamp, P. B., Becker, A., Puhler, A., Reiss, G. & Bruckl, H. (2004). Comparison 
of a prototype magnetoresistive biosensor to standard fluorescent DNA 
detection. Biosensors & Bioelectronics 19(10): 1149-1156. 
Schratzberger, P., Reinisch, N., Prodinger, W. M., Kahler, C. M., Sitte, B. A., Bellmann, R., 
FischerColbrie, R., Winkler, H. & Wiedermann, C. J. (1997). Differential 
chemotactic activities of sensory neuropeptides for human peripheral blood 
mononuclear cells. Journal of Immunology 158(8): 3895-3901. 
Schwalbe, M., Pachmann, K., Hoffken, K. & Clement, J. H. (2006). Improvement of the 
separation of tumour cells from peripheral blood cells using magnetic 
nanoparticles. Journal of Physics-Condensed Matter 18(38): S2865-S2876. 
Stampfli, M. R., Miescher, S., Aebischer, I., Zurcher, A. W. & Stadler, B. M. (1994). 
Inhibition of human IgE synthesis by anti-IgE antibodies requires divalent 
recognition. European Journal of Immunology 24(9): 2161-2167. 
Takahashi, M., Yoshino, T. & Matsunaga, T. (2010). Surface modification of magnetic 
nanoparticles using asparagines-serine polypeptide designed to control 
interactions with cell surfaces. Biomaterials 31(18): 4952-4957. 
Tanaka, T., Maruyama, K., Yoda, K., Nemoto, E., Udagawa, Y., Nakayama, H., Takeyama, 
H. & Matsunaga, T. (2003). Development and evaluation of an automated 
workstation for single nucleotide polymorphism discrimination using bacterial 
magnetic particles. Biosensors & Bioelectronics 19(4): 325-330. 
www.intechopen.com
 
The Potential of Genetically Engineered Magnetic Particles in Biomedical Applications 
 
409 
Tanaka, T. & Matsunaga, T. (2000). Fully automated chemiluminescence immunoassay of 
insulin using antibody-protein A-bacterial magnetic particle complexes. 
Analytical Chemistry 72(15): 3518-3522. 
Tanaka, T., Takeda, H., Kokuryu, Y. & Matsunaga, T. (2004). Spontaneous integration of 
transmembrane peptides into a bacterial magnetic particle membrane and its 
application to display of useful proteins. Analytical Chemistry 76(13): 3764-3769. 
Tiwari, A., Punshon, G., Kidane, A., Hamilton, G. & Seifalian, A. M. (2003). Magnetic 
beads (Dynabead) toxicity to endothelial cells at high bead concentration: 
Implication for tissue engineering of vascular prosthesis. Cell Biology and 
Toxicology 19(5): 265-272. 
Ugelstad, J., Berge, A., Ellingsen, T., Aune, O., Kilaas, L., Nilsen, T. N., Schmid, R., 
Stenstad, P., Funderud, S., Kvalheim, G., Nustad, K., Lea, T., Vartdal, F. & 
Danielsen, H. (1988). Monosized magnetic particles and their use in selective cell 
separation. Makromolekulare Chemie-Macromolecular Symposia 17: 177-211. 
Weissleder, R., Kelly, K., Sun, E. Y., Shtatland, T. & Josephson, L. (2005). Cell-specific 
targeting of nanoparticles by multivalent attachment of small molecules. Nature 
Biotechnology 23: 1418-1423. 
Wright, L. D., Cresson, E. L., Skeggs, H. R., Wood, T. R., Peck, R. L., Wolf, D. E. & Folkers, 
K. (1952). Isolation of crystalline biocytin from yeast extract. Journal of the 
American Chemical Society 74(8): 1996-1999. 
Xu, C. J., Xu, K. M., Gu, H. W., Zhong, X. F., Guo, Z. H., Zheng, R. K., Zhang, X. X. & Xu, 
B. (2004). Nitrilotriacetic acid-modified magnetic nanoparticles as a general agent 
to bind histidine-tagged proteins. Journal of the American Chemical Society 126(11): 
3392-3393. 
Xu, L., Yu, H., Akhras, M. S., Han, S. J., Osterfeld, S., White, R. L., Pourmand, N. & Wang, 
S. X. (2008). Giant magnetoresistive biochip for DNA detection and HPV 
genotyping. Biosensors & Bioelectronics 24(1): 99-103. 
Yoshino, T., Kaji, C., Nakai, M., Saito, F., Takeyama, H. & Matsunaga, T. (2008). Novel 
method for evaluation of chemicals based on ligand-dependent recruitment of 
GFP labeled coactivator to estrogen receptor displayed on bacterial magnetic 
particles. Analytica Chimica Acta 626(1): 71-77. 
Yoshino, T., Kato, F., Takeyama, H., Nakai, M., Yakabe, Y. & Matsunaga, T. (2005). 
Development of a novel method for screening of estrogenic compounds using 
nano-sized bacterial magnetic particles displaying estrogen receptor. Analytica 
Chimica Acta 532(2): 105-111. 
Yoshino, T. & Matsunaga, T. (2005). Development of efficient expression system for 
protein display on bacterial magnetic particles. Biochemical and Biophysical 
Research Communications 338(4): 1678-1681. 
Yoshino, T. &Matsunaga, T. (2006). Efficient and stable display of functional proteins on 
bacterial magnetic particles using Mms13 as a novel anchor molecule. Applied and 
Environmental Microbiology 72(1): 465-471. 
Yoshino, T., Nishimura, T., Mori, T., Suzuki, S., Kambara, H., Takeyama, H. & Matsunaga, 
T. (2009). Nano-sized bacterial magnetic particles displaying pyruvate phosphate 
dikinase for pyrosequencing. Biotechnology and Bioengineering 103(1): 130-137. 
www.intechopen.com
 
Biomedical Engineering – From Theory to Applications 
 
410 
Yoshino, T., Shimojo, A., Maeda, Y. & Matsunaga, T. (2010). Inducible Expression of 
Transmembrane Proteins on Bacterial Magnetic Particles in Magnetospirillum 
magneticum AMB-1. Applied and Environmental Microbiology 76(4): 1152-1157. 
Yoshino, T., Takahashi, M., Takeyama, H., Okamura, Y., Kato, F. & Matsunaga, T. (2004). 
Assembly of G protein-coupled receptors onto nanosized bacterial magnetic 
particles using Mms16 as an anchor molecule. Applied and Environmental 
Microbiology 70(5): 2880-2885. 
www.intechopen.com
Biomedical Engineering - From Theory to Applications
Edited by Prof. Reza Fazel
ISBN 978-953-307-637-9
Hard cover, 486 pages
Publisher InTech
Published online 29, August, 2011
Published in print edition August, 2011
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
In all different areas in biomedical engineering, the ultimate objectives in research and education are to
improve the quality life, reduce the impact of disease on the everyday life of individuals, and provide an
appropriate infrastructure to promote and enhance the interaction of biomedical engineering researchers. This
book is prepared in two volumes to introduce a recent advances in different areas of biomedical engineering
such as biomaterials, cellular engineering, biomedical devices, nanotechnology, and biomechanics. It is hoped
that both of the volumes will bring more awareness about the biomedical engineering field and help in
completing or establishing new research areas in biomedical engineering.
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